Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Verastem Board Member Bought in at $11.53

Verastem, board member: On Monday October 7th, Richard Aldrich, a member of the Board of Directors at Verastem Inc (NASDAQ:VSTM), purchased 1,000 shares of common stock at a price of $11.53 each, for a total value of $11,530. The operation increased the holding of Richard H. Aldrich 2005 Revocable Trust to 15,000 shares of common stock, valued at $165,900.


Those shares are under Mr. Aldrich’s indirect control, as are another 2,869,841 shares of common stock owned by Longwood Fund, L.P. worth approximately $31,740,441, and 135,714 shares of common stock under the control of Richard H. Aldrich Irrevocable Trust of 2011 said to be worth 1,500,996. Last, Mr. Aldrich holds under his direct control an additional 407,142 shares of common stock for an estimated worth of $4,502,990.

Since July, Mr. Aldrich has been very active completing 15 transactions. In addition to yesterday’s purchase, Mr. Aldrich has registered 5 transactions in July totaling 5,000 shares of common stock with prices ranging from $14.11 to $17.19, another 4,000 shares of common stock through August paying between $13.45-15.25 each, and 5,000 shares of common stock more in September at an average price of $13.52.

The stock’s price has entered a free fall after hitting a historical high at $17.19 per share on July 12th, 2013. Yesterday, its price stood at $11.09, which is lower than any of the prices paid by Mr. Aldrich. And the largest hedge fund holding a position within the company is Qvt Financial, led by Daniel Gold, with 271,101 shares of common stock, followed by Sophrosyne Capital, led by Benjamin J. Taylor, with 223,043 shares of common stock, and Bridger Management, led by Roberto Mignone, with 200,000 shares of common stock.

Disclosure: Jodor Jalit holds no position in any of the mentioned stocks.

Recommended Reading:

Alico Director Gordon Walker is Behaving Bullishly Today

Oiltanking Partners Insider is Buying at $55 a Share

How One Anacor Pharmaceuticals Insider is Making Bank

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!